Medicines labeled for the same conditions

Alternatives to emtricitabine and rilpivirine and tenofovir disoproxil

29 other medicines are given the same way (oral) and in the same FDA class as emtricitabine and rilpivirine and tenofovir disoproxil or labeled mainly for the same use (HIV); 13 are in its class, human immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitors: lamivudine, etravirine, abacavir, lamivudine and zidovudine and 9 more; the others include 5 cytochrome p450 3a inhibitors, 4 protease inhibitors and 3 human immunodeficiency virus integrase strand transfer inhibitors (FDA labels read October 8, 2026). In the same class, the lowest pharmacy cost is $0.147 per nevirapine 200 mg tablet (what pharmacies paid in the NADAC survey; strengths differ).

Which medicines are labeled for the same conditions as emtricitabine and rilpivirine and tenofovir disoproxil?

The first 24 of the 29, the same class first. HIV lists all 47 medicines labeled for it, by any route. Each row shows the conditions both labels name. They are listed as public records, not as substitutes: whether one can replace another depends on the person and is a prescriber's decision.

Medicine and FDA class	Shared indication	Generic labelers (oral)	Pharmacy cost	Boxed warning	Shortage
Emtricitabine and rilpivirine and tenofovir disoproxilhuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor	this medicine	2 labelers	$114.50 per tablet 200-25-300 mg tablet	Yes	No current entry
Lamivudinehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same class	HIV	14 labelers	$0.489 per tablet 150 mg tablet	Yes	No current entry
Etravirinehuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same class	HIV	5 labelers	$9.94 per tablet 200 mg tablet	No	A presentation being discontinued
Abacavirhuman immunodeficiency virus nucleoside analog reverse transcriptase inhibitor · same class	HIV	12 labelers	$0.546 per tablet 300 mg tablet	Yes	No current entry
Lamivudine and zidovudinehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same class	HIV	7 labelers	$0.771 per tablet Lamivudine-zidovudine tablet	Yes	No current entry
Nevirapinehuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same class	HIV	6 labelers	$0.147 per tablet 200 mg tablet	Yes	No current entry
Efavirenzhuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same class	HIV	5 labelers	$1.28 per tablet 600 mg tablet	No	No current entry
Zidovudinehuman immunodeficiency virus nucleoside analog reverse transcriptase inhibitor · same class	HIV	3 labelers	$0.464 per tablet 300 mg tablet	Yes	No current entry
Abacavir and lamivudinehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same class	HIV	6 labelers	$1.48 per unit 600-300 mg	Yes	No current entry
Doravirinehuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same class	HIV	none listed	$60.79 per tablet 100 mg tablet	No	No current entry
Abacavir and dolutegravir and lamivudinehuman immunodeficiency virus integrase strand transfer inhibitor · same class	HIV	none listed	$130.01 per tablet 600-50-300 mg tablet	Yes	No current entry
Abacavir and lamivudine and zidovudinehepatitis b virus nucleoside analog reverse transcriptase inhibitor · same class	HIV	1 labeler	n/a	Yes	No current entry
Dolutegravir and lamivudinehuman immunodeficiency virus integrase strand transfer inhibitor · same class	HIV	none listed	$105.22 per tablet 50-300 mg tablet	Yes	No current entry
Doravirine and islatravirhuman immunodeficiency virus 1 non-nucleoside analog reverse transcriptase inhibitor · same class	HIV	none listed	n/a	No	No current entry
Darunavirprotease inhibitor	HIV	13 labelers	$1.16 per tablet 600 mg tablet	No	No current entry
Maravirocccr5 co-receptor antagonist	HIV	8 labelers	$9.15 per tablet 150 mg tablet	Yes	A presentation being discontinued
Atazanavirprotease inhibitor	HIV	4 labelers	$2.23 per capsule 300 mg capsule	No	No current entry
Ritonavircytochrome p450 3a inhibitor	HIV	7 labelers	$0.607 per tablet 100 mg tablet	Yes	A presentation being discontinued
Lopinavir and ritonavircytochrome p450 3a inhibitor	HIV	3 labelers	$4.46 per tablet 200-50 mg tablet	No	A presentation being discontinued
Raltegravirhuman immunodeficiency virus integrase strand transfer inhibitor	HIV	1 labeler	$34.54 per tablet 400 mg tablet	No	No current entry
Dolutegravirhuman immunodeficiency virus integrase strand transfer inhibitor	HIV	none listed	$77.64 per tablet 50 mg tablet	No	No current entry
Cobicistat and darunavircytochrome p450 3a inhibitor	HIV	none listed	$79.99 per tablet 800 mg-150 mg tablet	No	No current entry
Fosamprenavirprotease inhibitor	HIV	2 labelers	n/a	No	No current entry
Lenacapavirhuman immunodeficiency virus 1 capsid inhibitor	HIV	none listed	n/a	No	No current entry
Nelfinavirprotease inhibitor	HIV	none listed	n/a	No	No current entry

Source: FDA drug labels (indications) via openFDA; FDA NDC Directory; CMS NADAC of October 7, 2026; FDA Drug Shortage Database (FDA files October 8, 2026)

What do pharmacies pay for each?

The headline NADAC price per unit of each medicine's most widely listed form; strengths differ, so compare like with like on each record.

Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price

What next?

Emtricitabine and rilpivirine and tenofovir disoproxil: the full record: label, generics, price, shortages, recalls